Th2 Cytokine Genotypes Are Associated with a Milder Form of Primary Sjogren's Syndrome

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2005 Sep 17

PMID 16166103

Citations 14

Authors

M Pertovaara

J Antonen

M Hurme

Affiliations

Soon will be listed here.

Abstract

Background: Immunohistological studies on salivary and lacrimal glands have yielded conflicting results on the Th1/Th2 balance in primary Sjögren's syndrome (pSS).

Objective: To establish whether pSS is a Th1 or Th2 directed autoimmune disease by analysing the polymorphism of the genes encoding for cytokines involved in the regulation of Th1/Th2 differentiation.

Methods: The polymorphisms of the genes encoding for interleukin 4 (IL4) -590 C/T, interleukin 13 (IL13) +2044 G/A, and interferon gamma (IFNG) +874 T/A were analysed in 63 white Finnish patients with pSS (61 female, two male) and in 63 healthy controls. The clinical and immunological data on the pSS patients were analysed in relation to these cytokine gene polymorphisms.

Results: There were no significant differences in the genotype or allele frequencies of IL4 -590, IL13 +2044, or IFNG +874 between pSS patients and controls. The erythrocyte sedimentation rate and concentrations of serum IgA and serum beta2 microglobulin were lower in pSS patients carrying the IL4 -590 T allele or the IL13 +2044 A allele than in those not carrying the respective alleles. The IL4 -509 T allele and IL13 +2044 A allele carriers less often had purpura than the corresponding non-carriers.

Conclusions: The frequencies of the cytokine genotypes regulating Th1/Th2 differentiation did not differ between pSS patients and controls. However, the presence of cytokine genotypes with increased susceptibility to atopic and other Th2 diseases was associated with signs of a milder form of pSS. This finding would favour a hypothesis envisaging pSS as primarily a Th1 mediated autoimmune disease.

Citing Articles

Polymorphisms in Pathways in Pediatric Astrocytomas.

Morais de Castro E, Barbosa L, Fonseca A, Nagashima S, De Paula C, Zeni R ASN Neuro. 2023; 15:17590914231153481.

PMID: 36714975 PMC: 9903018. DOI: 10.1177/17590914231153481.

Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment.

An Q, Zhao J, Zhu X, Yang B, Wu Z, Su Y Front Immunol. 2022; 13:995895.

PMID: 36389806 PMC: 9650646. DOI: 10.3389/fimmu.2022.995895.

Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.

Masli S, Dartt D Int J Mol Sci. 2020; 21(23).

PMID: 33266081 PMC: 7730359. DOI: 10.3390/ijms21239112.

T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome.

Rios-Rios W, Sosa-Luis S, Torres-Aguilar H Biomolecules. 2020; 10(11).

PMID: 33187265 PMC: 7698113. DOI: 10.3390/biom10111539.

Contributions of Major Cell Populations to Sjögren's Syndrome.

Witas R, Gupta S, Nguyen C J Clin Med. 2020; 9(9).

PMID: 32971904 PMC: 7564211. DOI: 10.3390/jcm9093057.

References

Villarreal G, Alcocer-Varela J, Llorente L . Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome. Immunol Lett. 1996; 49(1-2):105-9. DOI: 10.1016/0165-2478(95)02490-5. View

Font J, Filella X, Cervera R, Ramos-Casals M, Siso A, Aymami A . Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol. 2001; 19(4):411-5. View

Hagiwara E, Pando J, Ishigatsubo Y, Klinman D . Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol. 1998; 25(1):89-93. View

Ajjan R, McIntosh R, Waterman E, Watson P, Franklin C, Yeoman C . Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome. Br J Rheumatol. 1998; 37(2):179-85. DOI: 10.1093/rheumatology/37.2.179. View

Konttinen Y, Kemppinen P, Koski H, Li T, Jumppanen M, Hietanen J . T(H)1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals. Scand J Rheumatol. 1999; 28(2):106-12. DOI: 10.1080/030097499442577. View

Kolkowski E, Reth P, Pelusa F, Bosch J, Pujol-Borrell R, Coll J . Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. J Autoimmun. 1999; 13(1):155-62. DOI: 10.1006/jaut.1999.0289. View

Pertovaara M, Korpela M, Kouri T, Pasternack A . The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology (Oxford). 1999; 38(11):1113-20. DOI: 10.1093/rheumatology/38.11.1113. View

Jabs D, Lee B, Whittum-Hudson J, PRENDERGAST R . Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci. 2000; 41(3):826-31. View

Noguchi E, Jian Z, Yokouchi Y, Kamioka M, Hamaguchi H, Matsui A . Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol. 2001; 62(11):1251-7. DOI: 10.1016/s0198-8859(01)00338-x. View

10.

Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y . Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002; 3(2):107-9. DOI: 10.1038/sj.gene.6363830. View

11.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View

12.

Mitsias D, Tzioufas A, Veiopoulou C, Zintzaras E, Tassios I, Kogopoulou O . The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol. 2002; 128(3):562-8. PMC: 1906267. DOI: 10.1046/j.1365-2249.2002.01869.x. View

13.

Genevay S, di Giovine F, Perneger T, Silvestri T, Stingelin S, Duff G . Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum. 2002; 47(3):303-9. DOI: 10.1002/art.10394. View

14.

Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea A, Cervera R, Ingelmo M . The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology (Oxford). 2002; 41(9):1025-30. DOI: 10.1093/rheumatology/41.9.1025. View

15.

Skopouli F, Dafni U, Ioannidis J, Moutsopoulos H . Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum. 2000; 29(5):296-304. DOI: 10.1016/s0049-0172(00)80016-5. View

16.

Kohriyama K, Katayama Y . Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome. Autoimmunity. 2000; 32(1):67-72. DOI: 10.3109/08916930008995989. View

17.

Pravica V, Perrey C, Stevens A, Lee J, Hutchinson I . A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000; 61(9):863-6. DOI: 10.1016/s0198-8859(00)00167-1. View

18.

van Roon J, Bijlsma J . Th2 mediated regulation in RA and the spondyloarthropathies. Ann Rheum Dis. 2002; 61(11):951-4. PMC: 1753949. DOI: 10.1136/ard.61.11.951. View

19.

Vercelli D . Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol. 2003; 2(5):389-93. DOI: 10.1097/00130832-200210000-00004. View

20.

Rossouw M, Nel H, Cooke G, van Helden P, Hoal E . Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet. 2003; 361(9372):1871-2. DOI: 10.1016/S0140-6736(03)13491-5. View